title: Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both.
authors.affiliation: Laboratorie d'Antibiologie Clinique et Expérimentale, Faculté de Médecine, C.H.U., Nantes, France.
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Xiong
authors.forename: J
authors.initials: J
authors.lastname: Caillon
authors.forename: X Y
authors.initials: XY
authors.lastname: Zhou
authors.forename: G
authors.initials: G
authors.lastname: Potel
authors.forename: D
authors.initials: D
authors.lastname: Bugnon
authors.forename: P
authors.initials: P
authors.lastname: Le Conte
authors.forename: F
authors.initials: F
authors.lastname: Le Gallou
authors.forename: R
authors.initials: R
authors.lastname: Le Floch
authors.forename: D
authors.initials: D
authors.lastname: Baron
authors.forename: H
authors.initials: H
authors.lastname: Drugeon
mesh_terms: D000583:Amikacin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D001021:Aortic Valve; D002442:Ceftazidime / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination; D004696:Endocarditis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006349:Heart Valve Diseases / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011817:Rabbits; D013407:Sulbactam / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D001618:beta-Lactamases / Q000096:biosynthesis
chemical_list: D000583:Amikacin; D002442:Ceftazidime; D001618:beta-Lactamases; D013407:Sulbactam